mivacurium and Lymphoma--T-Cell

Mivacurium is a benzylisoquinolone, choline-like, non-depolarizing muscle relaxant. Its onset of action is similar to that of atracurium but its duration of action is shorter (approximately 10-15 minutes). Mivacurium is metabolized by plasma cholinesterases at approximately 70% of the rate of metabolism of suxamethonium. Deficiency or abnormality of plasma cholinesterase may cause the duration of action of both suxamethonium and mivacurium to be greatly prolonged. We describe a case of prolonged mivacurium paralysis after day surgery. Laboratory investigations showed a genetic tendency toward abnormal cholinesterase levels, but markedly depressed cholinesterase activity was suggestive of additional acquired causes. This patient had a history of liver disease, malnutrition and anticholinesterase use, which we believe were the most significant factors involved.

Topics: Aged; Ambulatory Surgical Procedures; Biopsy, Needle; Endoscopy; Follow-Up Studies; Humans; Isoquinolines; Lymphoma, T-Cell; Male; Mivacurium; Paralysis; Risk Assessment; Severity of Illness Index; Time Factors; Tongue